A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis | MicrobiomeTrials← Back to trialsNCT07470879
A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-05-28Est. Completion: 2030-09-08
Enrollment target: 24 participants Locations- Investigational Drug Services - Riley Hospital, Indianapolis, Indiana, United States
- IU Health North Hospital, Indianapolis, Indiana, United States
- Riley Hospital for Children at IU Health, Indianapolis, Indiana, United States
- Fink Children's Ambulatory Care Center, New York, New York, United States
- Kimmel Pavilion - NYU Langone, New York, New York, United States
- NYU Grossman School of Medicine, New York, New York, United States
- NYU Langone Health (Tisch Hospital), New York, New York, United States
- NYU Langone Inflammatory Bowel Disease Center, New York, New York, United States
- NYU Langone Radiology - Tisch Hospital, New York, New York, United States
- NYU Medical Science Building (MSB), New York, New York, United States
- The Children's Hospital at Westmead, Westmead, New South Wales, Australia
- Queensland Children's Hospital, Brisbane, Queensland, Australia
- Monash Health, Clayton, Victoria, Australia
- Perth Children's Hospital, Perth, Western Australia, Australia
- University of Alberta, Edmonton, Alberta, Canada
Other microbiome trials you might be interested in
Inflammatory Bowel Diseases (IBD)Crohn DiseaseColitis, Ulcerative
Difficult-to-treat inflammatory bowel disease (DTT-IBD) represents a heterogeneous group of patients with treatment-refr…
Multiple LocationsEst. completion Oct 31, 2032
Inflammatory Bowel Disease
This study evaluates oral Lactobacillus reuteri as an adjunct therapy for 2 months. Endoscopic assessments will be perfo…
Suqian, ChinaCompleted Mar 30, 2026
Health Sciences Centre Winnipeg, Winnipeg, Manitoba, CanadaChildren's Hospital Research Institute of Manitoba, Winnipeg, Manitoba, CanadaCHU de Québec - Université Laval, Québec, Quebec, CanadaHospices Civils de Lyon - Hôpital Femme Mère Enfant, Bron, FranceHôpital Universitaire Necker Enfants Malades, Paris, FranceUniversitätsklinikum Münster, Klinik für Kinder- und Jugendmedizin Albert-Schweitzer-Campus 1, Münster, North Rhine-Westphalia, GermanyUniversitätsklinikum Leipzig, Leipzig, Saxony, GermanyUniversitaetsklinikum Tuebingen, Tübingen, GermanyHELIOS Klinikum Wuppertal, Wuppertal, GermanySheba Medical Center, Ramat Gan, Central District, IsraelKaplan Medical Center, Rehovot, Central District, IsraelYitzhak Shamir Medical Center, Ẕerifin, Central District, IsraelShaare Zedek Medical Center, Jerusalem, Jerusalem, IsraelHadassah Medical Center, Jerusalem, Jerusalem, IsraelRambam Health Care Campus, Haifa, Northern District, IsraelCarmel Medical Center, Haifa, Northern District, IsraelAzienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Lombardy, ItalyFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Lombardy, ItalyAzienda Ospedaliera Universitaria Meyer IRCCS, Florence, Tuscany, ItalySaitama Prefectural Children's Medical Center, Saitama-shi, Saitama, JapanJapanese Red Cross Kumamoto Hospital, Kumamoto, JapanJuntendo University Hospital, Tokyo, JapanCentrum Zdrowia MDM, Warsaw, Masovian Voivodeship, PolandMedical Network Spółka z o.o. WIP Warsaw IBD Point Profesor Kierkuś, Warsaw, Masovian Voivodeship, PolandGyncentrum sp. z o.o. NZOZ Holsamed - oddział Libero, Katowice, PolandInstytut "Pomnik - Centrum Zdrowia Dziecka", Warsaw, PolandKing's College Hospital, London, London, CITY of, United KingdomBristol Royal Hospital for Children, Bristol, United KingdomAlder Hey Children's Hospital, Liverpool, United KingdomEvelina London Children's Hospital, London, United KingdomSheffield Children's Hospital, Sheffield, United KingdomRecruiting
Recurrent C. Difficile (rCDI)Ulcerative Colitis (UC)Metabolic Syndrome (MetS)
The gut microbiota plays a key role in immunity and metabolism and contributes to diseases such as recurrent C. difficil…
Rome, ItalyEst. completion Jan 19, 2029